Niranjan Sardesai, Chief Operating Officer at INOVIO PHARMACEUTICALS, INC. (INO), sold 21,800 shares at $9.30 ($203K) on 2016-08-29, disclosed to the SEC on 2016-08-30.
Open-market sale of $203k INO by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| INO | BUY | 2014-08-12 | $22K | — | Filing → |
| INO | BUY | 2013-03-22 | $13K | — | Filing → |
| INO | BUY | 2012-05-17 | $5K | — | Filing → |